Testosterone therapy in glucocorticoid-treated men

Archives of Internal Medicine

Volumn 156, Issue 11, 1996, Pages 1173-1177

  Reid, Ian R ^a   Wattie, Diana J ^a   Evans, Margaret C ^a   Stapleton, Joanne P ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CALCIUM CARBONATE; CALCIUM LACTOGLUCONATE; GLUCOCORTICOID; PREDNISONE; TESTOSTERONE; TESTOSTERONE ESTER;

ADULT; AGED; ARTICLE; ASTHMA; BODY COMPOSITION; BODY FAT; BONE DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; LEAN BODY WEIGHT; LUMBAR SPINE; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ASTHMA; BODY COMPOSITION; BONE DENSITY; CALCIUM; GLUCOCORTICOIDS; HUMANS; LIPIDS; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 0030004314     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.11.1173     Document Type: Article

References (29)

1. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 1983;309:265-268.
2. Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax. 1991;46:803-806.
3. Michel BA, Bloch DA, Fries JF. Predictors of fractures in early rheumafoid arthritis. J Rheumatol 1991;16:804-808.
4. Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol (Oxf). 1989;30:83-103.
5. Reid IR, France JT, Pybus J, Ibbertson HK. Low plasma testosterone levels in glucocorticoid-treated male asthmatics. BMJ. 1985;291:574.
6. MacAdams MR, White RH, Cipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med. 1986;104:648-651.
7. Reid IR, Veale AG, France JT. Glucocorticoid osteoporosis. J Asthma. 1994;31:7-18.
8. Takeuchi M, Kakushi H, Tonkin M. Androgens directly stimulate mineralization and increase androgen receptors in human osteoblast-like osteosarcoma cells. Biochem Biophys Res Commun. 1994;204:905-911.
9. Murphy S, Khaw KT, Cassidy A, Compston JE. Sex hormones and bone mineral density in elderly men. Bone Miner. 1993;20:133-140.
10. Kubler A, Schulz G, Cordes U, Beyer J, Krause U. The influence of testosterone substitution on bone mineral density in patients with Klinefelter's syndrome. Exp Clin Endocrinol. 1992;100:129-132.
11. Devogelaer JP, Decooman S, Dedeuxchaisnes CN. Low bone mass in hypogonadal males - effect of testosterone substitution therapy: a densitometric study. Maturitas. 1992;15:17-23.
12. Isaia S, Mussetta M, Pecchio F, Sciolla A, Distefano M, Molinatti GM. Effect of testosterone on bone in hypogonadal males. Maturitas. 1992;15:47-51.
13. Finkelstein JS, Klibanski A, Nerr RM. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1989;69:776-783.
14. Young NR, Baker HWG, Liu GD, Seeman E. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception. J Clin Endocrinol Metab. 1993;77:1028-1032.
15. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992;75:1092-1098.
16. Forbes GB, Porta CR, Herr BE, Griggs RC. Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA. 1992;267:397-399.
17. Reid IR, Ames R, Evans MC, et al. Determinants of total body and regional bone mineral density in normal postmenopausal women - a key role for fat mass. J Clin Endocrinol Metab. 1992;75:45-51.
18. Grey AB, Stapleton JP, Evans MC, Reid IR. The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women. J Clin Endocrinol Metab. 1995;80:3191-3195.
19. Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet. 1988;1:143-146.
20. Diamond T, McGuigan L, Barbagallo S, Bryant C. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women. Am J Med. 1995;98:459-463.
21. Sambrook P, Birmingham J, Kelly P, et al. Prevention of corticosteroid osteoporosis - a comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993;328:1747-1752.
22. Reid IR, Evans MC, Stapleton J. Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res. 1992;7:1221-1225.
23. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. Testosterone administration increases insulin-like growth factor-1 levels in normal men. J Clin Endocrinol Metab. 1993;77:776-779.
24. Weissberger AJ, Ho KKY. Activation of the somatotropic axis by testosterone in adult males - evidence for the role of aromatization. J Clin Endocrinol Metab. 1993;76:1407-1412.
25. Arisaka O, Arisaka M, Nakayama Y, Fujiwara S, Yabuta K. Effect of testosterone on bone density and bone metabolism in adolescent male hypogonadism. Metabolism. 1995;44:419-423.
26. Bellido T, Jilka RL, Boyce BF, et al. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens: the role of the androgen receptor. J Clin Invest. 1995;95:2886-2895.
27. Rebuffe-Scrive M, Marin P, Biorntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes Relat Metab Disord. 1991;15:791-795.
28. Cigolini M, Smith U. Human adipose tissue in culture. VIII: studies on the insulin-antagonistic effect of glucocorticoids. Metabolism. 1979;28:502-510.
29. Behre HM, Bohmeyer J, Nieschlag E. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol (Oxf). 1994;40:341-349.